<DOC>
	<DOC>NCT00365859</DOC>
	<brief_summary>This study will provide long-term safety data for patients who are taking aripiprazole for up to 1 year. Most patients enrolled in this study will have participated in a short-term study with aripiprazole (CN138-178 [NCT00332241] or CN138-179 [NCT00337571]).</brief_summary>
	<brief_title>Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Problem Behavior</mesh_term>
	<mesh_term>Behavioral Symptoms</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Inclusion Criteria Rollover: Completed 8 weeks of treatment in one of the following doubleblind clinical trials: CN138178 [NCT00332241] or CN138179 [NCT00337571] No significant protocol violations and sufficient medical justification to continue on openlabel treatment with aripiprazole Inclusion Criteria De Novo: Meets current Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSMIV TR) diagnostic criteria for AD and demonstrates serious behavioral problems diagnosis confirmed by Autism Diagnostic InterviewRevised (ADIR) or the patient meets the current Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSMIV TR) diagnostic criteria for AD and has a history of behavioral problems that are currently being treated with psychotropic medication Mental age of at least 18 months Male or female 6 to 17 years of age, inclusive, at the time of enrollment Patients considered treatment resistant to neuroleptic medication based on lack of therapeutic response to 2 different neuroleptics after treatment of at least 3 weeks each Patients previously treated and not responding to aripiprazole treatment The patient is currently diagnosed with another disorder on the autism spectrum, including pervasive developmental disordernot otherwise specified (PDDNOS), Asperger's Disorder, Rett's Disorder, FragileX Syndrome or Childhood Disintegrative Disorder Current diagnosis of bipolar disorder, psychosis, schizophrenia, or major depression A seizure in the past year History of severe head trauma or stroke Nonpharmacologic therapy (e.g. psychotherapy, behavior modification) should be stable prior to screening and consistent throughout the study</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Serious behavioral problems in children and adolescents with AD</keyword>
	<keyword>behavioral problems</keyword>
</DOC>